Biol Psychiatry
July 14, 2026
correction
Erratum to: Calcium/Calmodulin-Dependent Protein Kinase II and Eukaryotic Elongation Factor 2 Kinase Pathways Mediate the Antidepressant Action of Ketamine.
Biol Psychiatry
July 1, 2026
Dynamic Brain States With Cannabis Intoxication: Beyond "More Is Better" in Interpreting Brain Connectivity.
Biol Psychiatry
May 1, 2026
Keeping an Open Mind About (and With) Psychedelics.
Biol Psychiatry
August 1, 2021
Luke G. Petry, Monica Sharma, Aaron Wolfgang et al.
4 citations
Any Questions? A Sober Look at MDMA.
Biol Psychiatry
May 30, 2019
Strengthened Hippocampal Circuits Underlie Enhanced Retrieval of Extinguished Fear Memories Following Mindfulness Training.
Biol Psychiatry
May 25, 2018
Philipp Sterzer, Rick A. Adams, Paul Fletcher et al.
901 citations
Fueled by developments in computational neuroscience, there has been increasing interest in the underlying neurocomputational mechanisms of psychosis. One successful approach involves predictive coding and Bayesian inference. Here, inferences regarding the current state of the world are made by combining prior beliefs with incoming sensory signals. Mismatches between prior beliefs and incoming...
Biol Psychiatry
December 1, 2010
Is ecstasy an empathogen?
Biol Psychiatry
October 14, 2010
Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.
Biol Psychiatry
March 1, 2002
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
Biol Psychiatry
May 1, 1996
Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
Biol Psychiatry
1995
Autonomous psychosis following psychotogenic substance abuse.
Biol Psychiatry
July 1, 1989
Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
Biol Psychiatry
July 1, 1986
Spectral EEG correlates of dream recall.
Biol Psychiatry
1986
A new metabolic pathway for N,N-dimethyltryptamine.